Covid-19 vaccine: Bharat Biotech's Covaxin 'highly efficacious', says The Lancet

Bharat Biotech's Covaxin was found to have a 77.8% efficacy rate against symptomatic Covid-19 patients, The Lancet said.Covaxin 'induces a robust antibody response' two weeks after two doses are given

from mint - News https://ift.tt/3D98sEH
https://ift.tt/eA8V8J